Biotechnology
The Biotechnology industry has a total of 680 stocks, with a combined market cap of $1,394.62 billion and total revenue of $120.43 billion.
Market Cap
1,394.62B
Revenue
120.43B
Profits
-34.35B
PE Ratio
n/a
Profit Margin
-28.52%
Dividend Yield
0.10%
680 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 559.94B | 2.70% | 3,700,021 | 33.32B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 104.59B | 1.25% | 1,069,746 | 9.87B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 97.94B | 0.80% | 340,941 | 13.12B |
| 4 | MRNA | Moderna, Inc. | 41.31B | 3.28% | 2,427,279 | 6.85B |
| 5 | ARGX | argenx SE | 22.29B | 1.72% | 340,247 | 39.48M |
| 6 | BNTX | BioNTech SE | 21.04B | 0.55% | 359,338 | 4.24B |
| 7 | GMAB | Genmab A/S | 18.67B | -1.42% | 557,666 | 2.44B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.47B | 0.19% | 532,485 | 1.83B |
| 9 | BMRN | BioMarin Pharmaceutical Inc. | 17.47B | 2.87% | 1,268,430 | 2.42B |
| 10 | BGNE | BeiGene, Ltd. | 14.93B | 6.15% | 201,776 | 2.46B |
| 11 | SKYE | Skye Bioscience, Inc. | 13.63B | -5.27% | 136,864 | - |
| 12 | RPRX | Royalty Pharma plc | 12.43B | - | 3,478,123 | 2.35B |
| 13 | INCY | Incyte Corporation | 11.60B | -0.52% | 2,493,671 | 3.70B |
| 14 | UTHR | United Therapeutics Corporation | 11.03B | 0.18% | 400,101 | 2.33B |
| 15 | SRPT | Sarepta Therapeutics, Inc. | 10.99B | 0.14% | 440,864 | 1.24B |
| 16 | TECH | Bio-Techne Corporation | 10.01B | 1.42% | 1,217,169 | 1.14B |
| 17 | ROIV | Roivant Sciences Ltd. | 8.82B | 3.21% | 4,946,079 | 123.24M |
| 18 | LEGN | Legend Biotech Corporation | 8.63B | 0.83% | 1,440,885 | 285.14M |
| 19 | ASND | Ascendis Pharma A/S | 8.20B | 1.92% | 205,213 | 296.35M |
| 20 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.62B | -0.26% | 1,345,372 | - |
| 21 | VKTX | Viking Therapeutics, Inc. | 7.10B | 1.69% | 2,007,609 | - |
| 22 | EXEL | Exelixis, Inc. | 6.87B | 1.84% | 1,865,864 | 1.83B |
| 23 | CYTK | Cytokinetics, Incorporated | 6.86B | -1.09% | 1,167,152 | 7.53M |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 6.84B | 0.77% | 360,778 | 3.83B |
| 25 | PCVX | Vaxcyte, Inc. | 6.62B | -1.17% | 622,839 | - |
| 26 | IONS | Ionis Pharmaceuticals, Inc. | 6.10B | 1.87% | 614,603 | 787.65M |
| 27 | RVMD | Revolution Medicines, Inc. | 5.97B | -0.47% | 1,340,992 | 11.58M |
| 28 | APLS | Apellis Pharmaceuticals, Inc. | 5.87B | 2.27% | 1,057,492 | 396.59M |
| 29 | BPMC | Blueprint Medicines Corporation | 5.65B | 1.85% | 767,342 | 249.38M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 4.95B | 0.67% | 526,071 | 829.25M |
| 31 | CRSP | CRISPR Therapeutics AG | 4.79B | 1.35% | 1,187,186 | 371.21M |
| 32 | BBIO | BridgeBio Pharma, Inc. | 4.70B | 1.56% | 1,097,090 | 9.30M |
| 33 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.58B | 2.29% | 409,527 | - |
| 34 | KRYS | Krystal Biotech, Inc. | 4.58B | 3.05% | 219,153 | 50.70M |
| 35 | NUVL | Nuvalent, Inc. | 4.33B | 4.82% | 478,159 | - |
| 36 | ALPN | Alpine Immune Sciences, Inc. | 4.23B | -0.05% | 3,104,151 | 58.88M |
| 37 | IMVT | Immunovant, Inc. | 4.16B | -0.45% | 1,032,598 | - |
| 38 | INSM | Insmed Incorporated | 3.75B | 4.81% | 2,022,522 | 305.21M |
| 39 | RARE | Ultragenyx Pharmaceutical Inc. | 3.71B | 3.25% | 836,694 | 434.25M |
| 40 | IBRX | ImmunityBio, Inc. | 3.70B | 11.13% | 30,579,691 | 622.00K |
| 41 | AXSM | Axsome Therapeutics, Inc. | 3.46B | 2.78% | 703,022 | 270.60M |
| 42 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.45B | 1.80% | 589,301 | 4.01M |
| 43 | IOVA | Iovance Biotherapeutics, Inc. | 3.31B | 4.77% | 3,810,802 | 1.19M |
| 44 | FTRE | Fortrea Holdings Inc. | 3.30B | 4.00% | 923,460 | 3.11B |
| 45 | SWTX | SpringWorks Therapeutics, Inc. | 3.25B | 2.59% | 850,773 | 5.45M |
| 46 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.23B | 3.34% | 2,087,103 | - |
| 47 | FOLD | Amicus Therapeutics, Inc. | 3.16B | -1.02% | 3,985,123 | 399.36M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 3.10B | 2.70% | 311,522 | - |
| 49 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.95B | -0.59% | 803,217 | 181.74M |
| 50 | IDYA | IDEAYA Biosciences, Inc. | 2.91B | 3.80% | 486,098 | 23.39M |
| 51 | ACLX | Arcellx, Inc. | 2.87B | 4.69% | 385,613 | 110.32M |
| 52 | APGE | Apogee Therapeutics, Inc. | 2.86B | 2.32% | 274,201 | - |
| 53 | IMCR | Immunocore Holdings plc | 2.85B | 2.67% | 298,691 | 249.43M |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 2.76B | -1.47% | 1,404,429 | 726.44M |
| 55 | MOR | MorphoSys AG | 2.72B | 0.45% | 180,913 | 264.75M |
| 56 | MLTX | MoonLake Immunotherapeutics | 2.70B | 5.44% | 576,471 | - |
| 57 | SMMT | Summit Therapeutics Inc. | 2.62B | 6.88% | 1,754,665 | - |
| 58 | JANX | Janux Therapeutics, Inc. | 2.57B | 1.84% | 706,616 | 8.08M |
| 59 | CLDX | Celldex Therapeutics, Inc. | 2.43B | -2.78% | 418,705 | 6.88M |
| 60 | CGON | CG Oncology, Inc. | 2.42B | 8.26% | 414,025 | 204.00K |
| 61 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.41B | 2.54% | 413,648 | 77.43M |
| 62 | CORT | Corcept Therapeutics Incorporated | 2.38B | 3.14% | 1,866,689 | 482.38M |
| 63 | MRUS | Merus N.V. | 2.36B | 0.91% | 569,770 | 43.95M |
| 64 | ARVN | Arvinas, Inc. | 2.32B | -2.58% | 522,589 | 78.50M |
| 65 | DNLI | Denali Therapeutics Inc. | 2.30B | 0.75% | 1,062,333 | 330.53M |
| 66 | VCEL | Vericel Corporation | 2.25B | 2.29% | 326,907 | 197.52M |
| 67 | TGTX | TG Therapeutics, Inc. | 2.20B | 1.06% | 3,213,857 | 233.66M |
| 68 | KYMR | Kymera Therapeutics, Inc. | 2.18B | 3.96% | 437,029 | 78.59M |
| 69 | VERA | Vera Therapeutics, Inc. | 2.17B | 1.00% | 1,216,326 | - |
| 70 | RCKT | Rocket Pharmaceuticals, Inc. | 2.14B | -0.84% | 451,474 | - |
| 71 | NTLA | Intellia Therapeutics, Inc. | 2.08B | -1.37% | 848,177 | 36.28M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.06B | 2.29% | 794,732 | - |
| 73 | GERN | Geron Corporation | 2.06B | -6.17% | 10,377,197 | 237.00K |
| 74 | RNA | Avidity Biosciences, Inc. | 2.00B | 4.06% | 847,780 | 9.56M |
| 75 | KROS | Keros Therapeutics, Inc. | 1.99B | -1.06% | 476,075 | 151.00K |
| 76 | PTCT | PTC Therapeutics, Inc. | 1.95B | -2.16% | 743,411 | 937.82M |
| 77 | GLPG | Galapagos NV | 1.94B | 1.31% | 115,815 | 266.36M |
| 78 | BEAM | Beam Therapeutics Inc. | 1.92B | -2.61% | 1,359,887 | 377.71M |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 1.91B | 6.03% | 170,366 | 15.66M |
| 80 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.87B | 3.29% | 55,386,317 | 251.46M |
| 81 | FUSN | Fusion Pharmaceuticals Inc. | 1.82B | 0.47% | 1,864,401 | 2.07M |
| 82 | SANA | Sana Biotechnology, Inc. | 1.78B | 2.02% | 1,677,430 | - |
| 83 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.05% | 727,820 | - |
| 84 | AGIO | Agios Pharmaceuticals, Inc. | 1.77B | 5.30% | 1,224,626 | 26.82M |
| 85 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.74B | -2.45% | 990,001 | 398.20M |
| 86 | GPCR | Structure Therapeutics Inc. | 1.68B | 0.19% | 423,991 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | 1.32% | 4,808,595 | 44.58M |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 1.64B | -1.70% | 414,776 | 582.02M |
| 89 | NMRA | Neumora Therapeutics, Inc. | 1.64B | -1.06% | 328,683 | - |
| 90 | INBX | Inhibrx, Inc. | 1.62B | 0.09% | 240,333 | 1.80M |
| 91 | PTGX | Protagonist Therapeutics, Inc. | 1.56B | 0.90% | 325,247 | 60.00M |
| 92 | ADMA | ADMA Biologics, Inc. | 1.52B | 5.48% | 2,752,108 | 258.22M |
| 93 | ZLAB | Zai Lab Limited | 1.49B | 0.87% | 466,116 | 266.72M |
| 94 | ARDX | Ardelyx, Inc. | 1.49B | -1.84% | 3,818,102 | 124.46M |
| 95 | EWTX | Edgewise Therapeutics, Inc. | 1.46B | 3.78% | 468,373 | - |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 1.45B | 8.19% | 6,594,674 | - |
| 97 | AKRO | Akero Therapeutics, Inc. | 1.45B | 1.01% | 537,296 | - |
| 98 | MORF | Morphic Holding, Inc. | 1.44B | 0.88% | 509,084 | 521.00K |
| 99 | KURA | Kura Oncology, Inc. | 1.43B | 2.97% | 1,018,993 | - |
| 100 | RCUS | Arcus Biosciences, Inc. | 1.41B | 5.59% | 582,461 | 117.00M |
| 101 | GYRE | Gyre Therapeutics, Inc. | 1.36B | -0.13% | 39,463 | 113.45M |
| 102 | SLNO | Soleno Therapeutics, Inc. | 1.30B | 6.93% | 400,606 | - |
| 103 | FDMT | 4D Molecular Therapeutics, Inc. | 1.27B | -5.99% | 565,453 | 20.72M |
| 104 | TARS | Tarsus Pharmaceuticals, Inc. | 1.26B | 4.40% | 211,725 | 17.45M |
| 105 | VRNA | Verona Pharma plc | 1.25B | -0.83% | 356,558 | - |
| 106 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.25B | 3.42% | 594,774 | 270.26M |
| 107 | SYRE | Spyre Therapeutics, Inc. | 1.24B | 2.87% | 201,520 | 886.00K |
| 108 | LGND | Ligand Pharmaceuticals Incorporated | 1.24B | 1.98% | 140,672 | - |
| 109 | PIRS | Pieris Pharmaceuticals, Inc. | 1.19B | 2.67% | 115,342 | 42.81M |
| 110 | SRRK | Scholar Rock Holding Corporation | 1.18B | 5.64% | 735,273 | - |
| 111 | ABCL | AbCellera Biologics Inc. | 1.16B | -1.00% | 1,583,939 | 38.03M |
| 112 | MIRM | Mirum Pharmaceuticals, Inc. | 1.14B | 1.03% | 414,056 | 186.37M |
| 113 | MNKD | MannKind Corporation | 1.12B | 1.22% | 993,288 | 198.96M |
| 114 | XNCR | Xencor, Inc. | 1.12B | 0.88% | 463,975 | 168.34M |
| 115 | PRTA | Prothena Corporation plc | 1.10B | -3.43% | 419,434 | 91.37M |
| 116 | BLTE | Belite Bio, Inc | 1.10B | 7.31% | 38,820 | - |
| 117 | VIR | Vir Biotechnology, Inc. | 1.10B | 0.37% | 762,454 | 86.18M |
| 118 | IMTX | Immatics N.V. | 1.07B | 2.26% | 383,921 | 60.00M |
| 119 | SLN | Silence Therapeutics plc | 1.06B | 0.04% | 143,348 | 32.12M |
| 120 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.02B | 4.75% | 2,241,196 | 288.95M |
| 121 | MGNX | MacroGenics, Inc. | 1.01B | 5.32% | 646,310 | 58.75M |
| 122 | ARQT | Arcutis Biotherapeutics, Inc. | 1.00B | -2.24% | 1,591,749 | 59.61M |
| 123 | ABVX | Abivax SA | 997.87M | 1.67% | 78,207 | 5.13M |
| 124 | LQDA | Liquidia Corporation | 984.56M | -1.75% | 1,162,072 | 17.49M |
| 125 | BCYC | Bicycle Therapeutics plc | 962.35M | 0.49% | 163,465 | 26.98M |
| 126 | INVA | Innoviva, Inc. | 959.16M | 1.61% | 1,475,016 | 310.46M |
| 127 | MDXG | MiMedx Group, Inc. | 956.70M | 2.36% | 747,532 | 321.48M |
| 128 | CNTA | Centessa Pharmaceuticals plc | 928.48M | -6.00% | 173,152 | 6.85M |
| 129 | BCRX | BioCryst Pharmaceuticals, Inc. | 902.94M | -0.68% | 4,233,738 | 331.41M |
| 130 | VRDN | Viridian Therapeutics, Inc. | 894.44M | -0.35% | 524,456 | 314.00K |
| 131 | ZNTL | Zentalis Pharmaceuticals, Inc. | 891.97M | -3.31% | 379,195 | - |
| 132 | SAVA | Cassava Sciences, Inc. | 888.28M | 0.24% | 497,635 | - |
| 133 | EYPT | EyePoint Pharmaceuticals, Inc. | 875.53M | 3.66% | 930,561 | 46.02M |
| 134 | PHVS | Pharvaris N.V. | 869.84M | 2.01% | 88,764 | - |
| 135 | TYRA | Tyra Biosciences, Inc. | 860.34M | 5.68% | 146,715 | - |
| 136 | NRIX | Nurix Therapeutics, Inc. | 838.16M | 4.05% | 681,923 | 80.89M |
| 137 | PRAX | Praxis Precision Medicines, Inc. | 834.57M | 2.22% | 246,516 | 2.45M |
| 138 | ETNB | 89bio, Inc. | 834.03M | -4.19% | 745,416 | - |
| 139 | TNGX | Tango Therapeutics, Inc. | 829.20M | 6.29% | 581,751 | 36.53M |
| 140 | KYTX | Kyverna Therapeutics, Inc. | 827.38M | -1.59% | 122,470 | - |
| 141 | SPRY | ARS Pharmaceuticals, Inc. | 820.26M | 3.53% | 510,339 | 30.00K |
| 142 | ELVN | Enliven Therapeutics, Inc. | 813.01M | -1.42% | 366,478 | - |
| 143 | AUTL | Autolus Therapeutics plc | 779.97M | -1.75% | 1,723,639 | 1.70M |
| 144 | RGNX | REGENXBIO Inc. | 778.99M | 1.66% | 345,845 | 90.24M |
| 145 | SAGE | Sage Therapeutics, Inc. | 778.38M | 0.47% | 806,957 | 86.46M |
| 146 | ALXO | ALX Oncology Holdings Inc. | 777.36M | 8.92% | 438,556 | - |
| 147 | RLAY | Relay Therapeutics, Inc. | 773.96M | -0.84% | 782,653 | 25.55M |
| 148 | PLRX | Pliant Therapeutics, Inc. | 754.19M | -0.63% | 236,712 | 1.58M |
| 149 | ARCT | Arcturus Therapeutics Holdings Inc. | 751.74M | 3.22% | 314,124 | 166.80M |
| 150 | CRGX | CARGO Therapeutics, Inc. | 747.90M | -0.16% | 93,197 | - |
| 151 | OCUL | Ocular Therapeutix, Inc. | 743.14M | -1.48% | 2,272,184 | 58.44M |
| 152 | AUPH | Aurinia Pharmaceuticals Inc. | 736.11M | 0.79% | 903,857 | 175.51M |
| 153 | LBPH | Longboard Pharmaceuticals, Inc. | 730.07M | 8.57% | 497,564 | - |
| 154 | COGT | Cogent Biosciences, Inc. | 723.23M | -2.25% | 952,719 | - |
| 155 | CGEM | Cullinan Oncology, Inc. | 717.90M | 6.65% | 954,048 | - |
| 156 | PRTC | PureTech Health plc | 706.60M | - | 124 | 15.62M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 687.30M | 0.77% | 177,144 | 2.83M |
| 158 | ENGN | enGene Holdings Inc. | 672.98M | 3.11% | 51,280 | - |
| 159 | YMAB | Y-mAbs Therapeutics, Inc. | 671.54M | 1.19% | 508,895 | 84.82M |
| 160 | IRON | Disc Medicine, Inc. | 666.39M | 0.07% | 544,173 | - |
| 161 | PHAR | Pharming Group N.V. | 664.63M | 4.09% | 793 | 272.57M |
| 162 | SVRA | Savara Inc. | 647.91M | -0.21% | 450,726 | - |
| 163 | AVTE | Aerovate Therapeutics, Inc. | 646.98M | 4.74% | 148,072 | - |
| 164 | CABA | Cabaletta Bio, Inc. | 642.58M | - | 744,958 | - |
| 165 | HLVX | HilleVax, Inc. | 636.67M | -1.31% | 160,686 | - |
| 166 | IMNM | Immunome, Inc. | 626.42M | -4.06% | 890,514 | 14.02M |
| 167 | MNMD | Mind Medicine (MindMed) Inc. | 625.34M | 2.19% | 1,198,771 | - |
| 168 | WVE | Wave Life Sciences Ltd. | 621.20M | 4.96% | 450,738 | 113.31M |
| 169 | LYEL | Lyell Immunopharma, Inc. | 619.99M | 1.24% | 687,088 | 130.00K |
| 170 | ZYME | Zymeworks Inc. | 604.06M | -1.72% | 327,500 | 76.01M |
| 171 | ORIC | ORIC Pharmaceuticals, Inc. | 590.89M | 0.57% | 270,385 | - |
| 172 | GHRS | GH Research PLC | 587.92M | -3.58% | 42,063 | - |
| 173 | NVAX | Novavax, Inc. | 586.40M | 2.95% | 3,577,420 | 983.71M |
| 174 | NUVB | Nuvation Bio Inc. | 584.36M | - | 885,422 | - |
| 175 | STOK | Stoke Therapeutics, Inc. | 583.42M | - | 601,239 | 8.78M |
| 176 | CVAC | CureVac N.V. | 582.10M | 2.77% | 607,858 | 45.62M |
| 177 | MESO | Mesoblast Limited | 582.07M | 8.50% | 629,465 | 7.25M |
| 178 | PROK | ProKidney Corp. | 581.70M | -6.99% | 1,148,574 | - |
| 179 | PRME | Prime Medicine, Inc. | 575.71M | 0.42% | 750,763 | - |
| 180 | ALLO | Allogene Therapeutics, Inc. | 569.84M | -0.88% | 1,582,538 | 95.00K |
| 181 | MLYS | Mineralys Therapeutics, Inc. | 567.28M | 2.60% | 139,123 | - |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 559.15M | 1.32% | 566,169 | - |
| 183 | EXAI | Exscientia plc | 550.58M | 3.06% | 355,178 | 25.42M |
| 184 | KRRO | Korro Bio, Inc. | 545.01M | -0.64% | 70,403 | - |
| 185 | OABI | OmniAb, Inc. | 543.46M | -0.85% | 350,365 | 34.16M |
| 186 | VERV | Verve Therapeutics, Inc. | 540.42M | -0.43% | 963,342 | 11.76M |
| 187 | VALN | Valneva SE | 538.71M | -4.05% | 804 | 170.79M |
| 188 | ALT | Altimmune, Inc. | 536.68M | 1.34% | 3,126,273 | 426.00K |
| 189 | NKTX | Nkarta, Inc. | 532.74M | 2.30% | 703,348 | - |
| 190 | ABSI | Absci Corporation | 531.22M | 4.43% | 1,233,130 | 5.72M |
| 191 | PHAT | Phathom Pharmaceuticals, Inc. | 529.81M | 0.55% | 575,806 | 682.00K |
| 192 | ATXS | Astria Therapeutics, Inc. | 529.27M | -1.63% | 743,638 | - |
| 193 | AVBP | ArriVent BioPharma, Inc. | 528.20M | -0.82% | 86,586 | - |
| 194 | CELC | Celcuity Inc. | 525.01M | -1.71% | 90,262 | - |
| 195 | FATE | Fate Therapeutics, Inc. | 516.73M | -5.02% | 3,992,798 | 63.53M |
| 196 | ANAB | AnaptysBio, Inc. | 513.32M | -2.44% | 381,270 | 17.16M |
| 197 | ALEC | Alector, Inc. | 511.30M | 3.29% | 541,627 | 97.06M |
| 198 | APLT | Applied Therapeutics, Inc. | 509.52M | 1.13% | 388,329 | 9.99M |
| 199 | URGN | UroGen Pharma Ltd. | 495.79M | 1.11% | 216,640 | 82.71M |
| 200 | ABUS | Arbutus Biopharma Corporation | 495.48M | 4.17% | 1,088,049 | 18.14M |
| 201 | CALT | Calliditas Therapeutics AB (publ) | 488.42M | -0.38% | 1,880 | 105.88M |
| 202 | CCCC | C4 Therapeutics, Inc. | 473.34M | 0.58% | 911,554 | 20.76M |
| 203 | TSHA | Taysha Gene Therapies, Inc. | 473.16M | 2.85% | 1,458,338 | 15.45M |
| 204 | KALV | KalVista Pharmaceuticals, Inc. | 472.93M | -2.01% | 192,435 | - |
| 205 | HUMA | Humacyte, Inc. | 468.00M | 6.22% | 2,151,230 | - |
| 206 | ANNX | Annexon, Inc. | 466.58M | -2.31% | 801,528 | - |
| 207 | FULC | Fulcrum Therapeutics, Inc. | 460.80M | 2.62% | 510,498 | 2.81M |
| 208 | IGMS | IGM Biosciences, Inc. | 453.90M | 14.07% | 413,494 | 2.13M |
| 209 | STTK | Shattuck Labs, Inc. | 450.54M | 2.04% | 317,137 | 1.66M |
| 210 | THRD | Third Harmonic Bio, Inc. | 449.89M | -5.15% | 793,029 | - |
| 211 | EDIT | Editas Medicine, Inc. | 449.00M | -2.50% | 1,620,744 | 78.12M |
| 212 | SLRN | Acelyrin, Inc. | 447.76M | -4.56% | 2,027,898 | - |
| 213 | TBPH | Theravance Biopharma, Inc. | 444.08M | -2.54% | 335,572 | 57.42M |
| 214 | OCS | Oculis Holding AG | 438.70M | - | 306,321 | 1.05M |
| 215 | TVTX | Travere Therapeutics, Inc. | 436.81M | -1.88% | 1,244,602 | 145.24M |
| 216 | TRDA | Entrada Therapeutics, Inc. | 433.12M | -1.60% | 42,822 | 129.01M |
| 217 | CDMO | Avid Bioservices, Inc. | 422.44M | 4.21% | 702,777 | 140.94M |
| 218 | HRTX | Heron Therapeutics, Inc. | 420.92M | 8.11% | 6,551,327 | 127.04M |
| 219 | VYGR | Voyager Therapeutics, Inc. | 415.40M | 1.06% | 366,047 | 250.01M |
| 220 | LRMR | Larimar Therapeutics, Inc. | 412.15M | 0.94% | 235,886 | - |
| 221 | ADCT | ADC Therapeutics SA | 411.59M | 6.20% | 401,770 | 69.56M |
| 222 | LENZ | LENZ Therapeutics, Inc. | 406.49M | 0.19% | 120,392 | - |
| 223 | NGNE | Neurogene Inc. | 400.63M | 1.83% | 57,922 | - |
| 224 | LXEO | Lexeo Therapeutics, Inc. | 399.98M | -4.11% | 82,172 | - |
| 225 | CTNM | Contineum Therapeutics, Inc. | 399.83M | 1.08% | 25,447 | 50.00M |
| 226 | LXRX | Lexicon Pharmaceuticals, Inc. | 396.44M | -5.85% | 3,512,819 | 1.20M |
| 227 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 396.01M | 0.11% | 500,508 | - |
| 228 | CBUS | Cibus, Inc. | 396.00M | -0.06% | 121,290 | 1.82M |
| 229 | REPL | Replimune Group, Inc. | 394.11M | - | 1,136,327 | - |
| 230 | ITOS | iTeos Therapeutics, Inc. | 393.92M | 1.85% | 295,177 | 12.60M |
| 231 | MREO | Mereo BioPharma Group plc | 389.36M | -0.36% | 790,047 | 10.00M |
| 232 | BMEA | Biomea Fusion, Inc. | 388.70M | 1.39% | 685,328 | - |
| 233 | MRSN | Mersana Therapeutics, Inc. | 387.07M | 1.90% | 1,877,964 | 36.86M |
| 234 | TRML | Tourmaline Bio, Inc. | 387.01M | -2.65% | 374,107 | - |
| 235 | RVNC | Revance Therapeutics, Inc. | 381.43M | 0.55% | 1,587,204 | 234.04M |
| 236 | PEPG | PepGen Inc. | 379.60M | 2.90% | 13,415 | - |
| 237 | ADPT | Adaptive Biotechnologies Corporation | 374.34M | 2.79% | 1,496,135 | 170.28M |
| 238 | ANRO | Alto Neuroscience, Inc. | 373.15M | 1.76% | 85,381 | - |
| 239 | FBLG | FibroBiologics, Inc. | 363.18M | 2.68% | 48,353 | - |
| 240 | CRBU | Caribou Biosciences, Inc. | 359.45M | -0.25% | 898,065 | 34.48M |
| 241 | AURA | Aura Biosciences, Inc. | 357.42M | 1.83% | 107,856 | - |
| 242 | TNYA | Tenaya Therapeutics, Inc. | 349.40M | 0.45% | 140,474 | - |
| 243 | PGEN | Precigen, Inc. | 348.49M | 1.45% | 503,370 | 6.23M |
| 244 | SLDB | Solid Biosciences Inc. | 343.97M | 0.77% | 297,226 | - |
| 245 | RANI | Rani Therapeutics Holdings, Inc. | 337.27M | 0.30% | 91,074 | - |
| 246 | JSPR | Jasper Therapeutics, Inc. | 333.06M | -1.82% | 77,665 | - |
| 247 | ATAI | Atai Life Sciences N.V. | 327.07M | 5.35% | 1,158,766 | 314.00K |
| 248 | RNAC | Cartesian Therapeutics, Inc. | 324.66M | 12.76% | 122,978 | 26.00M |
| 249 | OCGN | Ocugen, Inc. | 321.66M | 0.81% | 6,852,888 | 6.04M |
| 250 | TCRX | TScan Therapeutics, Inc. | 316.58M | 1.97% | 200,753 | 21.05M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 313.93M | 1.63% | 179,618 | - |
| 252 | GUTS | Fractyl Health, Inc. | 313.60M | 0.15% | 145,585 | 120.00K |
| 253 | MGTX | MeiraGTx Holdings plc | 313.53M | -1.79% | 163,737 | - |
| 254 | NAUT | Nautilus Biotechnology, Inc. | 311.49M | 2.89% | 24,562 | - |
| 255 | LYRA | Lyra Therapeutics, Inc. | 311.26M | - | 228,906 | 1.56M |
| 256 | QTTB | Q32 Bio Inc. | 304.20M | 2.74% | 25,380 | 1.16M |
| 257 | XOMA | XOMA Corporation | 303.32M | 1.05% | 11,360 | 4.76M |
| 258 | TERN | Terns Pharmaceuticals, Inc. | 303.22M | -2.70% | 544,096 | - |
| 259 | ACRV | Acrivon Therapeutics, Inc. | 303.16M | 3.26% | 319,307 | - |
| 260 | CRMD | CorMedix Inc. | 298.73M | 3.22% | 572,517 | - |
| 261 | IMMP | Immutep Limited | 298.40M | 8.19% | 72,872 | 4.58M |
| 262 | AVXL | Anavex Life Sciences Corp. | 297.48M | - | 1,344,400 | - |
| 263 | ERAS | Erasca, Inc. | 292.38M | 4.32% | 441,697 | - |
| 264 | VRCA | Verrica Pharmaceuticals Inc. | 290.57M | 0.88% | 86,118 | 5.12M |
| 265 | RENB | Renovaro Biosciences Inc. | 290.21M | -6.05% | 292,109 | - |
| 266 | AKBA | Akebia Therapeutics, Inc. | 286.84M | 0.74% | 2,024,992 | 194.62M |
| 267 | STRO | Sutro Biopharma, Inc. | 286.15M | -1.33% | 722,428 | 153.73M |
| 268 | EPIX | ESSA Pharma Inc. | 283.12M | - | 130,486 | - |
| 269 | CYBN | Cybin Inc. | 282.99M | -1.50% | 2,919,513 | - |
| 270 | RAPT | RAPT Therapeutics, Inc. | 278.38M | 1.78% | 332,570 | - |
| 271 | OPT | Opthea Limited | 278.38M | -0.59% | 1,948 | 385.28K |
| 272 | ENTA | Enanta Pharmaceuticals, Inc. | 278.20M | -2.16% | 108,198 | 73.62M |
| 273 | GLUE | Monte Rosa Therapeutics, Inc. | 277.85M | 0.73% | 75,988 | - |
| 274 | HOWL | Werewolf Therapeutics, Inc. | 275.23M | 5.75% | 393,884 | 19.94M |
| 275 | INZY | Inozyme Pharma, Inc. | 271.80M | 0.23% | 742,565 | - |
| 276 | TVGN | Tevogen Bio Holdings Inc. | 271.61M | -1.20% | 102,081 | - |
| 277 | IVVD | Invivyd, Inc. | 270.63M | 3.65% | 830,157 | - |
| 278 | INO | Inovio Pharmaceuticals, Inc. | 268.65M | 3.49% | 241,971 | 832.01K |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 266.40M | -3.54% | 1,365,441 | 192.64M |
| 280 | MGX | Metagenomi, Inc. | 263.43M | 5.24% | 51,013 | 44.76M |
| 281 | PRLD | Prelude Therapeutics Incorporated | 262.27M | 0.52% | 24,853 | - |
| 282 | PYXS | Pyxis Oncology, Inc. | 261.60M | -0.66% | 383,845 | - |
| 283 | NKTR | Nektar Therapeutics | 260.74M | 4.41% | 1,100,016 | 90.12M |
| 284 | BDTX | Black Diamond Therapeutics, Inc. | 259.11M | -0.20% | 355,982 | - |
| 285 | VTYX | Ventyx Biosciences, Inc. | 257.75M | 1.16% | 444,785 | - |
| 286 | CDXC | ChromaDex Corporation | 256.05M | 15.25% | 461,190 | 83.57M |
| 287 | NBTX | Nanobiotix S.A. | 253.95M | -0.35% | 26,912 | 7.41M |
| 288 | ADAP | Adaptimmune Therapeutics plc | 250.43M | 12.87% | 1,132,949 | 60.28M |
| 289 | FENC | Fennec Pharmaceuticals Inc. | 250.40M | -1.49% | 288,706 | 21.25M |
| 290 | XERS | Xeris Biopharma Holdings, Inc. | 250.01M | - | 1,339,837 | 163.91M |
| 291 | XBIT | XBiotech Inc. | 248.97M | 2.89% | 154,280 | - |
| 292 | CHRS | Coherus BioSciences, Inc. | 247.43M | - | 797,450 | 257.24M |
| 293 | PBYI | Puma Biotechnology, Inc. | 247.30M | -0.77% | 292,944 | 235.64M |
| 294 | ANL | Adlai Nortye Ltd. | 244.02M | -14.56% | 20,838 | 5.00M |
| 295 | VSTM | Verastem, Inc. | 243.09M | -1.33% | 101,462 | - |
| 296 | QSI | Quantum-Si incorporated | 241.01M | 4.94% | 631,227 | 1.08M |
| 297 | TSVT | 2seventy bio, Inc. | 237.57M | -0.43% | 291,765 | 100.39M |
| 298 | BOLD | Boundless Bio, Inc. | 237.07M | 6.49% | 111,682 | - |
| 299 | ACIU | AC Immune SA | 236.09M | -1.65% | 189,450 | 17.62M |
| 300 | CDT | Conduit Pharmaceuticals Inc. | 232.56M | 2.27% | 14,164 | - |
| 301 | ALDX | Aldeyra Therapeutics, Inc. | 230.28M | -0.51% | 451,658 | - |
| 302 | ADVM | Adverum Biotechnologies, Inc. | 228.30M | -3.00% | 305,048 | 3.60M |
| 303 | QURE | uniQure N.V. | 227.23M | -1.45% | 314,023 | 15.84M |
| 304 | OVID | Ovid Therapeutics Inc. | 226.27M | 1.59% | 109,827 | 391.70K |
| 305 | FHTX | Foghorn Therapeutics Inc. | 219.64M | 2.18% | 45,662 | 34.16M |
| 306 | GTHX | G1 Therapeutics, Inc. | 218.72M | 2.20% | 354,842 | 82.51M |
| 307 | GBIO | Generation Bio Co. | 216.72M | 16.01% | 212,943 | 5.90M |
| 308 | LCTX | Lineage Cell Therapeutics, Inc. | 214.93M | - | 333,217 | 8.95M |
| 309 | MACK | Merrimack Pharmaceuticals, Inc. | 214.05M | - | 79,647 | - |
| 310 | ELEV | Elevation Oncology, Inc. | 210.17M | 6.67% | 327,428 | - |
| 311 | GALT | Galectin Therapeutics Inc. | 209.23M | 10.46% | 235,497 | - |
| 312 | PSTX | Poseida Therapeutics, Inc. | 208.42M | 0.23% | 421,977 | 64.70M |
| 313 | XFOR | X4 Pharmaceuticals, Inc. | 206.56M | -9.56% | 3,491,931 | - |
| 314 | DSGN | Design Therapeutics, Inc. | 204.97M | -5.91% | 161,509 | - |
| 315 | ATNM | Actinium Pharmaceuticals, Inc. | 204.60M | -2.93% | 185,216 | 81.00K |
| 316 | CDXS | Codexis, Inc. | 203.88M | 1.40% | 167,720 | 70.14M |
| 317 | IPSC | Century Therapeutics, Inc. | 203.21M | 2.62% | 75,104 | 2.24M |
| 318 | RIGL | Rigel Pharmaceuticals, Inc. | 199.93M | 0.88% | 518,880 | 116.88M |
| 319 | ZVRA | Zevra Therapeutics, Inc. | 198.89M | 0.22% | 134,815 | 27.46M |
| 320 | TRVI | Trevi Therapeutics, Inc. | 196.54M | -3.06% | 172,290 | - |
| 321 | CMPX | Compass Therapeutics, Inc. | 193.78M | 2.01% | 70,371 | - |
| 322 | IPHA | Innate Pharma S.A. | 191.60M | 3.95% | 2,625 | 68.49M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 189.85M | 0.96% | 270,683 | - |
| 324 | CLLS | Cellectis S.A. | 187.97M | -0.76% | 47,178 | 24.41M |
| 325 | BLUE | bluebird bio, Inc. | 187.08M | 1.78% | 4,770,050 | 21.73M |
| 326 | ATOS | Atossa Therapeutics, Inc. | 186.70M | 4.93% | 1,161,915 | - |
| 327 | VERU | Veru Inc. | 186.64M | 0.39% | 2,619,792 | 15.93M |
| 328 | CRDF | Cardiff Oncology, Inc. | 186.30M | -4.36% | 699,032 | 488.00K |
| 329 | INMB | INmune Bio, Inc. | 184.58M | -4.56% | 178,611 | 155.00K |
| 330 | OMER | Omeros Corporation | 179.04M | 0.32% | 210,645 | - |
| 331 | CGEN | Compugen Ltd. | 177.27M | 4.76% | 237,668 | 33.46M |
| 332 | OTLK | Outlook Therapeutics, Inc. | 176.99M | 1.36% | 151,332 | - |
| 333 | KOD | Kodiak Sciences Inc. | 174.85M | -2.63% | 327,249 | - |
| 334 | DRTS | Alpha Tau Medical Ltd. | 174.18M | 2.46% | 44,119 | - |
| 335 | CADL | Candel Therapeutics, Inc. | 173.44M | 6.68% | 447,573 | - |
| 336 | ACET | Adicet Bio, Inc. | 172.56M | 5.00% | 1,127,637 | - |
| 337 | TELO | Telomir Pharmaceuticals, Inc. | 172.33M | 2.41% | 26,219 | - |
| 338 | IVA | Inventiva S.A. | 172.30M | -2.66% | 3,905 | 25.74M |
| 339 | GNFT | Genfit S.A. | 171.17M | 0.29% | 2,152 | 42.42M |
| 340 | GLSI | Greenwich LifeSciences, Inc. | 169.22M | 3.55% | 35,868 | - |
| 341 | GOSS | Gossamer Bio, Inc. | 166.39M | -0.73% | 1,208,314 | - |
| 342 | SCPH | scPharmaceuticals Inc. | 166.21M | 0.88% | 85,258 | 13.59M |
| 343 | AEON | AEON Biopharma, Inc. | 163.92M | -8.90% | 70,808 | - |
| 344 | PRQR | ProQR Therapeutics N.V. | 163.25M | 1.00% | 176,095 | 10.58M |
| 345 | OBIO | Orchestra BioMed Holdings, Inc. | 161.71M | 0.44% | 29,268 | 2.76M |
| 346 | MDWD | MediWound Ltd. | 155.76M | 4.12% | 21,248 | 18.69M |
| 347 | ACHV | Achieve Life Sciences, Inc. | 154.13M | 2.04% | 51,613 | - |
| 348 | YS | YS Biopharma Co., Ltd. | 152.72M | 2.78% | 54,584 | - |
| 349 | CAPR | Capricor Therapeutics, Inc. | 151.84M | -2.43% | 478,266 | 25.18M |
| 350 | ZURA | Zura Bio Limited | 151.71M | 5.14% | 133,021 | - |
| 351 | CRVO | CervoMed Inc. | 149.88M | 1.67% | 15,730 | 7.14M |
| 352 | IMAB | I-Mab | 149.38M | - | 204,955 | 3.90M |
| 353 | RGLS | Regulus Therapeutics Inc. | 147.95M | 2.73% | 101,435 | - |
| 354 | RPTX | Repare Therapeutics Inc. | 141.73M | 3.07% | 174,551 | 51.13M |
| 355 | SGMT | Sagimet Biosciences Inc. | 136.59M | 6.20% | 359,194 | 2.00M |
| 356 | SYRS | Syros Pharmaceuticals, Inc. | 135.97M | 3.01% | 163,477 | 9.94M |
| 357 | AGEN | Agenus Inc. | 135.31M | 11.96% | 1,666,291 | 156.31M |
| 358 | AMLX | Amylyx Pharmaceuticals, Inc. | 132.18M | -1.52% | 1,470,442 | 380.79M |
| 359 | VXRT | Vaxart, Inc. | 131.82M | -2.24% | 1,548,511 | 7.38M |
| 360 | DBVT | DBV Technologies S.A. | 130.85M | 3.03% | 116,974 | 15.73M |
| 361 | ANVS | Annovis Bio, Inc. | 130.81M | 3.39% | 226,191 | - |
| 362 | VTGN | VistaGen Therapeutics, Inc. | 130.53M | 1.05% | 189,215 | 1.04M |
| 363 | OMGA | Omega Therapeutics, Inc. | 129.06M | -2.09% | 301,568 | 3.09M |
| 364 | VOR | Vor Biopharma Inc. | 128.25M | 3.30% | 209,450 | - |
| 365 | MOLN | Molecular Partners AG | 127.80M | - | 441 | 8.38M |
| 366 | KPTI | Karyopharm Therapeutics Inc. | 126.95M | -3.54% | 1,588,807 | 146.03M |
| 367 | CTXR | Citius Pharmaceuticals, Inc. | 122.07M | 4.51% | 669,560 | - |
| 368 | GLYC | GlycoMimetics, Inc. | 118.27M | 1.94% | 1,229,862 | 10.00K |
| 369 | RLMD | Relmada Therapeutics, Inc. | 117.98M | 1.03% | 143,631 | - |
| 370 | PDSB | PDS Biotechnology Corporation | 117.37M | 7.02% | 988,911 | - |
| 371 | SEER | Seer, Inc. | 117.24M | 8.38% | 1,542,988 | 16.66M |
| 372 | NVCT | Nuvectis Pharma, Inc. | 117.10M | -7.18% | 39,343 | - |
| 373 | ADAG | Adagene Inc. | 116.91M | - | 8,100 | 18.11M |
| 374 | COYA | Coya Therapeutics, Inc. | 116.63M | 0.38% | 23,651 | 6.00M |
| 375 | MCRB | Seres Therapeutics, Inc. | 114.77M | 21.68% | 11,816,243 | 126.33M |
| 376 | RZLT | Rezolute, Inc. | 114.76M | -19.21% | 932,358 | - |
| 377 | CTMX | CytomX Therapeutics, Inc. | 113.77M | 0.60% | 289,726 | 101.21M |
| 378 | IMUX | Immunic, Inc. | 111.51M | 0.81% | 203,478 | - |
| 379 | LIFE | aTyr Pharma, Inc. | 109.76M | -1.22% | 221,426 | 353.00K |
| 380 | BCAB | BioAtla, Inc. | 107.74M | 2.75% | 671,933 | - |
| 381 | SGMO | Sangamo Therapeutics, Inc. | 106.09M | 2.12% | 2,271,203 | 176.23M |
| 382 | FGEN | FibroGen, Inc. | 105.69M | -6.14% | 1,338,987 | 147.75M |
| 383 | ELYM | Eliem Therapeutics, Inc. | 103.95M | -3.10% | 86,005 | - |
| 384 | CLSD | Clearside Biomedical, Inc. | 102.37M | -2.84% | 232,128 | 8.23M |
| 385 | CLRB | Cellectar Biosciences, Inc. | 100.33M | -2.51% | 897,171 | - |
| 386 | BTAI | BioXcel Therapeutics, Inc. | 99.88M | 4.21% | 407,990 | 1.38M |
| 387 | VANI | Vivani Medical, Inc. | 98.96M | 7.78% | 88,001 | - |
| 388 | BRNS | Barinthus Biotherapeutics plc | 98.54M | -2.67% | 7,915 | 802.00K |
| 389 | ANIX | Anixa Biosciences, Inc. | 97.93M | 1.99% | 73,279 | 210.00K |
| 390 | VIGL | Vigil Neuroscience, Inc. | 97.74M | -6.69% | 67,149 | - |
| 391 | IOBT | IO Biotech, Inc. | 96.84M | - | 58,855 | - |
| 392 | ORMP | Oramed Pharmaceuticals Inc. | 95.22M | 0.86% | 30,698 | 1.34M |
| 393 | ELTX | Elicio Therapeutics, Inc. | 94.24M | -5.34% | 19,352 | - |
| 394 | GNLX | Genelux Corporation | 93.49M | 3.88% | 147,729 | 170.00K |
| 395 | ABEO | Abeona Therapeutics Inc. | 93.28M | -53.67% | 5,457,325 | 3.50M |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 92.86M | 4.34% | 370,887 | - |
| 397 | ALLK | Allakos Inc. | 92.27M | -0.94% | 262,268 | - |
| 398 | DMAC | DiaMedica Therapeutics Inc. | 91.86M | -3.59% | 5,290 | - |
| 399 | SLS | SELLAS Life Sciences Group, Inc. | 91.72M | 5.84% | 2,015,350 | - |
| 400 | ARMP | Armata Pharmaceuticals, Inc. | 91.46M | 0.80% | 16,769 | 4.53M |
| 401 | MIST | Milestone Pharmaceuticals Inc. | 90.35M | 4.29% | 90,337 | 1.00M |
| 402 | ALVR | AlloVir, Inc. | 90.21M | 3.66% | 280,003 | - |
| 403 | BYSI | BeyondSpring Inc. | 89.35M | 8.53% | 112,151 | 1.55M |
| 404 | CRIS | Curis, Inc. | 88.47M | 1.08% | 5,784 | 10.02M |
| 405 | PLX | Protalix BioTherapeutics, Inc. | 87.66M | 1.69% | 272,095 | 65.49M |
| 406 | ATRA | Atara Biotherapeutics, Inc. | 85.77M | 3.04% | 831,138 | 8.57M |
| 407 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 85.43M | -0.97% | 77,792 | - |
| 408 | TCON | TRACON Pharmaceuticals, Inc. | 84.18M | 1.65% | 54,896 | 12.05M |
| 409 | CMRX | Chimerix, Inc. | 82.55M | 1.25% | 182,037 | 324.00K |
| 410 | LPTX | Leap Therapeutics, Inc. | 81.93M | -0.31% | 88,640 | - |
| 411 | AFMD | Affimed N.V. | 81.47M | 7.00% | 21,998 | 9.19M |
| 412 | ALRN | Aileron Therapeutics, Inc. | 80.62M | - | 67,616 | - |
| 413 | IFRX | InflaRx N.V. | 80.08M | -0.73% | 97,130 | 70.10K |
| 414 | ONCY | Oncolytics Biotech Inc. | 79.94M | 1.92% | 55,895 | - |
| 415 | CVM | CEL-SCI Corporation | 79.35M | -2.65% | 185,868 | - |
| 416 | ENTX | Entera Bio Ltd. | 78.77M | 8.29% | 113,414 | - |
| 417 | MRNS | Marinus Pharmaceuticals, Inc. | 78.69M | -2.37% | 2,824,854 | 30.99M |
| 418 | GRTS | Gritstone bio, Inc. | 78.59M | -0.93% | 2,406,457 | 16.34M |
| 419 | LVTX | LAVA Therapeutics N.V. | 78.34M | 4.56% | 106,365 | 7.52M |
| 420 | ATHA | Athira Pharma, Inc. | 78.19M | -2.39% | 85,296 | - |
| 421 | CGTX | Cognition Therapeutics, Inc. | 78.00M | 7.53% | 136,475 | - |
| 422 | TLSA | Tiziana Life Sciences Ltd | 77.96M | 2.35% | 2,508,786 | - |
| 423 | SPRO | Spero Therapeutics, Inc. | 77.34M | 2.14% | 123,729 | 103.78M |
| 424 | CNTB | Connect Biopharma Holdings Limited | 76.59M | 2.96% | 73,418 | - |
| 425 | TPST | Tempest Therapeutics, Inc. | 75.90M | 5.56% | 396,508 | - |
| 426 | PASG | Passage Bio, Inc. | 75.78M | 7.89% | 53,690 | - |
| 427 | CRVS | Corvus Pharmaceuticals, Inc. | 75.03M | 6.25% | 137,275 | - |
| 428 | HOOK | HOOKIPA Pharma Inc. | 73.86M | 8.20% | 791,517 | 20.13M |
| 429 | CUE | Cue Biopharma, Inc. | 72.96M | -4.46% | 160,821 | 5.49M |
| 430 | ASMB | Assembly Biosciences, Inc. | 72.76M | 0.38% | 13,829 | - |
| 431 | PALI | Palisade Bio, Inc. | 71.81M | 20.08% | 23,346,096 | 250.00K |
| 432 | DTIL | Precision BioSciences, Inc. | 70.75M | 5.68% | 31,095 | 48.73M |
| 433 | TSBX | Turnstone Biologics Corp. | 70.68M | 4.79% | 79,260 | 19.31M |
| 434 | CARM | Carisma Therapeutics, Inc. | 70.62M | -9.09% | 125,371 | 14.92M |
| 435 | ANTX | AN2 Therapeutics, Inc. | 70.56M | 0.42% | 82,313 | - |
| 436 | ANEB | Anebulo Pharmaceuticals, Inc. | 70.28M | 2.26% | 793 | - |
| 437 | CELU | Celularity Inc. | 69.92M | 4.90% | 20,133 | 14.79M |
| 438 | TIL | Instil Bio, Inc. | 69.92M | 0.37% | 2,073 | - |
| 439 | LABP | Landos Biopharma, Inc. | 69.09M | - | 9,225 | - |
| 440 | CSBR | Champions Oncology, Inc. | 68.92M | 0.20% | 2,321 | 49.22M |
| 441 | GNTA | Genenta Science S.p.A. | 66.13M | 7.43% | 607 | - |
| 442 | RLYB | Rallybio Corporation | 65.79M | -1.69% | 237,596 | - |
| 443 | MNOV | MediciNova, Inc. | 65.23M | -0.75% | 9,332 | 1.00M |
| 444 | IKNA | Ikena Oncology, Inc. | 65.15M | 3.85% | 263,389 | 9.16M |
| 445 | MLEC | Moolec Science SA | 64.99M | -29.96% | 3,102,742 | 2.90M |
| 446 | THTX | Theratechnologies Inc. | 63.45M | 3.01% | 18,668 | 57.85M |
| 447 | LTRN | Lantern Pharma Inc. | 61.98M | 0.87% | 127,299 | - |
| 448 | MURA | Mural Oncology plc | 61.94M | 1.95% | 124,725 | - |
| 449 | CLGN | CollPlant Biotechnologies Ltd. | 61.85M | 2.27% | 12,622 | 10.96M |
| 450 | VTVT | vTv Therapeutics Inc. | 60.76M | 3.16% | 4,407 | - |
| 451 | IMMX | Immix Biopharma, Inc. | 60.71M | 7.98% | 79,945 | - |
| 452 | HCWB | HCW Biologics Inc. | 60.65M | -1.23% | 8,757 | 560.36K |
| 453 | EQ | Equillium, Inc. | 60.64M | 4.24% | 87,845 | 36.08M |
| 454 | KZR | Kezar Life Sciences, Inc. | 60.13M | 0.49% | 518,203 | 7.00M |
| 455 | ALGS | Aligos Therapeutics, Inc. | 59.77M | 2.82% | 96,855 | 15.53M |
| 456 | KRON | Kronos Bio, Inc. | 57.09M | -1.04% | 4,265,284 | 6.29M |
| 457 | RPHM | Reneo Pharmaceuticals, Inc. | 55.80M | -0.89% | 77,993 | - |
| 458 | INTS | Intensity Therapeutics, Inc. | 55.52M | 3.85% | 8,985 | - |
| 459 | GANX | Gain Therapeutics, Inc. | 54.98M | 6.94% | 66,417 | 55.18K |
| 460 | AVRO | AVROBIO, Inc. | 54.28M | 0.83% | 53,733 | - |
| 461 | ABIO | ARCA biopharma, Inc. | 52.93M | 5.80% | 209,278 | - |
| 462 | XRTX | XORTX Therapeutics Inc. | 52.89M | 2.08% | 8,303 | - |
| 463 | ELDN | Eledon Pharmaceuticals, Inc. | 52.27M | 6.93% | 190,022 | - |
| 464 | OCEA | Ocean Biomedical, Inc. | 51.28M | -1.66% | 161,172 | - |
| 465 | BLRX | BioLineRx Ltd. | 50.91M | -5.95% | 422,349 | 4.80M |
| 466 | CKPT | Checkpoint Therapeutics, Inc. | 50.21M | -1.03% | 347,605 | 103.00K |
| 467 | QNCX | Quince Therapeutics, Inc. | 47.97M | 4.72% | 129,357 | - |
| 468 | IMRX | Immuneering Corporation | 47.73M | -5.23% | 327,841 | - |
| 469 | OKYO | OKYO Pharma Limited | 46.53M | 3.70% | 28,544 | - |
| 470 | CDTX | Cidara Therapeutics, Inc. | 46.44M | -0.27% | 1,822,798 | 63.91M |
| 471 | JAGX | Jaguar Health, Inc. | 46.40M | -6.61% | 37,993,414 | 9.76M |
| 472 | MTNB | Matinas BioPharma Holdings, Inc. | 45.52M | 0.83% | 766,523 | 1.10M |
| 473 | AADI | Aadi Bioscience, Inc. | 45.18M | -3.16% | 83,949 | 24.35M |
| 474 | INAB | IN8bio, Inc. | 45.02M | 4.01% | 282,252 | - |
| 475 | DYAI | Dyadic International, Inc. | 43.17M | -2.61% | 8,753 | 2.90M |
| 476 | CLNN | Clene Inc. | 43.04M | 0.63% | 308,948 | 654.00K |
| 477 | NXTC | NextCure, Inc. | 42.80M | -4.97% | 90,125 | - |
| 478 | APLM | Apollomics, Inc. | 42.78M | 3.44% | 137,703 | - |
| 479 | CTCX | Carmell Therapeutics Corporation | 42.34M | 15.18% | 3,120 | - |
| 480 | BOLT | Bolt Biotherapeutics, Inc. | 42.32M | - | 50,375 | 7.88M |
| 481 | NKGN | NKGen Biotech, Inc. | 42.19M | 25.85% | 11,454,259 | - |
| 482 | SABS | SAB Biotherapeutics, Inc. | 40.22M | -1.13% | 786 | 2.24M |
| 483 | MRKR | Marker Therapeutics, Inc. | 39.40M | 5.86% | 11,862 | 3.31M |
| 484 | ICCC | ImmuCell Corporation | 38.99M | - | 109 | 17.47M |
| 485 | PMN | ProMIS Neurosciences, Inc. | 38.87M | -0.49% | 3,092 | - |
| 486 | XLO | Xilio Therapeutics, Inc. | 38.76M | -4.55% | 445,665 | - |
| 487 | CARA | Cara Therapeutics, Inc. | 38.65M | -3.19% | 178,011 | 20.97M |
| 488 | OCUP | Ocuphire Pharma, Inc. | 38.21M | 1.99% | 140,421 | 19.05M |
| 489 | ESLA | Estrella Immunopharma, Inc. | 37.71M | 1.98% | 1,221 | - |
| 490 | UNCY | Unicycive Therapeutics, Inc. | 37.19M | -6.96% | 243,117 | - |
| 491 | BCTX | BriaCell Therapeutics Corp. | 37.08M | 5.45% | 35,475 | - |
| 492 | BCLI | Brainstorm Cell Therapeutics Inc. | 35.88M | -2.80% | 166,389 | - |
| 493 | FBIO | Fortress Biotech, Inc. | 34.81M | 3.43% | 190,376 | 84.51M |
| 494 | TARA | Protara Therapeutics, Inc. | 34.30M | -1.64% | 411,609 | - |
| 495 | CASI | CASI Pharmaceuticals, Inc. | 33.64M | 3.29% | 11,847 | 33.88M |
| 496 | MAIA | MAIA Biotechnology, Inc. | 33.52M | 8.85% | 235,577 | - |
| 497 | EVGN | Evogene Ltd. | 33.37M | 0.73% | 37,773 | 5.64M |
| 498 | VIRX | Viracta Therapeutics, Inc. | 33.30M | -3.66% | 83,532 | - |
| 499 | VYNE | VYNE Therapeutics Inc. | 32.71M | -1.28% | 29,888 | 424.00K |
| 500 | IPA | ImmunoPrecise Antibodies Ltd. | 32.10M | -1.61% | 39,344 | 17.67M |
| 501 | ACHL | Achilles Therapeutics plc | 32.09M | -2.24% | 111,844 | - |
| 502 | NRXP | NRx Pharmaceuticals, Inc. | 31.99M | 1.67% | 106,317 | - |
| 503 | ICU | SeaStar Medical Holding Corporation | 31.92M | 12.41% | 2,021,249 | - |
| 504 | IGC | IGC Pharma Inc | 30.38M | 2.58% | 521,828 | 1.22M |
| 505 | INKT | MiNK Therapeutics, Inc. | 30.22M | -2.57% | 91,895 | - |
| 506 | DARE | Daré Bioscience, Inc. | 29.90M | 0.68% | 322,777 | 2.81M |
| 507 | ADXN | Addex Therapeutics Ltd | 29.65M | -2.80% | 12,934 | 1.96M |
| 508 | ACXP | Acurx Pharmaceuticals, Inc. | 29.52M | 3.03% | 29,486 | - |
| 509 | APRE | Aprea Therapeutics, Inc. | 29.16M | 4.07% | 2,596 | 583.23K |
| 510 | SPRB | Spruce Biosciences, Inc. | 28.85M | 1.33% | 1,022,240 | 10.09M |
| 511 | SRZN | Surrozen, Inc. | 28.82M | -3.46% | 2,309 | - |
| 512 | PTN | Palatin Technologies, Inc. | 28.24M | 1.74% | 140,549 | 7.10M |
| 513 | NTRB | Nutriband Inc. | 27.89M | 0.56% | 25,617 | 2.09M |
| 514 | LEXX | Lexaria Bioscience Corp. | 27.73M | -1.10% | 53,977 | 386.00K |
| 515 | EYEN | Eyenovia, Inc. | 27.46M | 5.05% | 875,876 | 3.79K |
| 516 | ACST | Acasti Pharma Inc. | 27.07M | -0.69% | 4,467 | - |
| 517 | BIVI | BioVie Inc. | 27.01M | 1.78% | 685,382 | - |
| 518 | FBRX | Forte Biosciences, Inc. | 26.88M | 2.58% | 4,626 | - |
| 519 | ITRM | Iterum Therapeutics plc | 25.95M | 1.94% | 36,228 | - |
| 520 | ONCT | Oncternal Therapeutics, Inc. | 25.94M | 5.03% | 882 | 785.00K |
| 521 | PLUR | Pluri Inc. | 25.93M | -0.20% | 8,499 | 357.00K |
| 522 | SLGL | Sol-Gel Technologies Ltd. | 25.77M | 0.41% | 8,826 | 1.55M |
| 523 | LPCN | Lipocine Inc. | 25.52M | -5.33% | 75,152 | -2.85M |
| 524 | VAXX | Vaxxinity, Inc. | 25.35M | -25.82% | 2,062,298 | - |
| 525 | SNSE | Sensei Biotherapeutics, Inc. | 25.01M | 7.18% | 85,180 | - |
| 526 | UBX | Unity Biotechnology, Inc. | 25.01M | 0.68% | 33,662 | - |
| 527 | SER | Serina Therapeutics Inc | 25.01M | 1.94% | 987 | 142.00K |
| 528 | GDTC | CytoMed Therapeutics Limited | 24.79M | -4.44% | 1,150 | - |
| 529 | ENLV | Enlivex Therapeutics Ltd. | 24.54M | 3.94% | 48,007 | - |
| 530 | NRSN | NeuroSense Therapeutics Ltd. | 23.57M | 0.74% | 79,269 | - |
| 531 | APM | Aptorum Group Limited | 22.94M | -2.83% | 34,534 | 1.20M |
| 532 | BIOR | Biora Therapeutics, Inc. | 22.93M | 5.43% | 382,085 | 4.00K |
| 533 | LUMO | Lumos Pharma, Inc. | 22.70M | 4.09% | 17,128 | 2.05M |
| 534 | CNTX | Context Therapeutics Inc. | 22.51M | 3.68% | 23,977 | - |
| 535 | SYBX | Synlogic, Inc. | 22.25M | 4.95% | 66,394 | 3.37M |
| 536 | MEIP | MEI Pharma, Inc. | 22.20M | -1.71% | 4,913 | 72.65M |
| 537 | LSTA | Lisata Therapeutics, Inc. | 22.01M | -0.38% | 12,604 | - |
| 538 | EVAX | Evaxion Biotech A/S | 21.59M | -1.19% | 24,906 | 73.00K |
| 539 | INDP | Indaptus Therapeutics, Inc. | 21.26M | 2.05% | 7,359 | - |
| 540 | AIM | AIM ImmunoTech Inc. | 21.23M | 1.31% | 255,647 | 202.00K |
| 541 | VINC | Vincerx Pharma, Inc. | 20.34M | 9.32% | 413,971 | - |
| 542 | RNXT | RenovoRx, Inc. | 20.24M | -1.64% | 2,916 | - |
| 543 | APTO | Aptose Biosciences Inc. | 19.33M | -1.60% | 71,789 | - |
| 544 | TCRT | Alaunos Therapeutics, Inc. | 19.22M | 10.09% | 46,515 | 5.00K |
| 545 | PHGE | BiomX Inc. | 19.13M | 17.42% | 206,848 | - |
| 546 | GLTO | Galecto, Inc. | 19.00M | 2.88% | 106,464 | - |
| 547 | NRXS | NeurAxis, Inc. | 18.60M | -11.18% | 17,984 | 2.46M |
| 548 | ATHE | Alterity Therapeutics Limited | 18.59M | - | 31,441 | - |
| 549 | KALA | Kala Pharmaceuticals, Inc. | 18.49M | 4.42% | 4,537 | - |
| 550 | PMCB | PharmaCyte Biotech, Inc. | 18.03M | -0.93% | 1,501 | - |
| 551 | ORGS | Orgenesis Inc. | 17.82M | 2.33% | 18,325 | 530.00K |
| 552 | BNTC | Benitec Biopharma Inc. | 17.78M | 2.08% | 26,289 | 61.00K |
| 553 | NERV | Minerva Neurosciences, Inc. | 17.69M | 1.61% | 4,397 | - |
| 554 | VBIV | VBI Vaccines Inc. | 17.30M | 0.91% | 113,409 | 8.68M |
| 555 | TRAW | Traws Pharma Inc | 16.84M | -0.82% | 55,524 | 226.00K |
| 556 | CDIO | Cardio Diagnostics Holdings, Inc. | 16.23M | 0.33% | 258,381 | 17.07K |
| 557 | IBIO | iBio, Inc. | 16.18M | 6.74% | 154,045 | 50.00K |
| 558 | DOMH | Dominari Holdings Inc. | 16.08M | - | 10,942 | 2.04M |
| 559 | COCP | Cocrystal Pharma, Inc. | 15.89M | 2.76% | 739 | - |
| 560 | KPRX | Kiora Pharmaceuticals, Inc. | 15.22M | 19.48% | 1,181,900 | - |
| 561 | NRBO | NeuroBo Pharmaceuticals, Inc. | 14.82M | -2.82% | 41,907 | - |
| 562 | ABVC | ABVC BioPharma, Inc. | 14.26M | 29.81% | 7,137,328 | 152.43K |
| 563 | EDSA | Edesa Biotech, Inc. | 14.16M | 1.48% | 2,327 | - |
| 564 | IMRN | Immuron Limited | 14.02M | -5.38% | 1,888 | 2.43M |
| 565 | SNTI | Senti Biosciences, Inc. | 13.73M | 6.80% | 19,750 | 2.56M |
| 566 | PPBT | Purple Biotech Ltd. | 13.48M | 8.07% | 82,114 | - |
| 567 | AVTX | Avalo Therapeutics, Inc. | 13.44M | 6.47% | 73,221 | 1.92M |
| 568 | NNVC | NanoViricides, Inc. | 13.43M | 1.79% | 11,602 | - |
| 569 | TNXP | Tonix Pharmaceuticals Holding Corp. | 13.25M | 0.90% | 1,568,252 | 7.77M |
| 570 | XTLB | XTL Biopharmaceuticals Ltd. | 12.71M | 1.17% | 7,560 | - |
| 571 | IMNN | Imunon, Inc. | 12.50M | 4.72% | 49,618 | - |
| 572 | COEP | Coeptis Therapeutics, Inc. | 11.43M | -3.18% | 50,883 | - |
| 573 | MNPR | Monopar Therapeutics Inc. | 11.35M | 2.85% | 85,351 | - |
| 574 | CANF | Can-Fite BioPharma Ltd. | 10.80M | -0.51% | 3,656 | 743.00K |
| 575 | ERNA | Eterna Therapeutics Inc. | 10.60M | -8.84% | 9,928 | 68.00K |
| 576 | GRTX | Galera Therapeutics, Inc. | 10.55M | 1.68% | 351,985 | - |
| 577 | ELAB | Elevai Labs, Inc. | 10.40M | 4.15% | 21,566 | 1.71M |
| 578 | MBRX | Moleculin Biotech, Inc. | 10.25M | - | 7,425 | - |
| 579 | IKT | Inhibikase Therapeutics, Inc. | 10.23M | 15.33% | 78,470 | 260.50K |
| 580 | BCDA | BioCardia, Inc. | 10.10M | 2.23% | 79,753 | 477.00K |
| 581 | ONVO | Organovo Holdings, Inc. | 10.04M | -2.91% | 124,516 | 242.00K |
| 582 | BNOX | Bionomics Limited | 9.87M | -3.82% | 43,017 | 15.00K |
| 583 | AEZS | Aeterna Zentaris Inc. | 9.57M | 1.03% | 2,671 | 4.50M |
| 584 | FRES | Fresh2 Group Ltd | 9.54M | 30.85% | 269,853 | 2.35M |
| 585 | CMMB | Chemomab Therapeutics Ltd. | 9.52M | 1.53% | 7,099 | - |
| 586 | KZIA | Kazia Therapeutics Limited | 9.34M | 3.13% | 135,525 | 15.65K |
| 587 | ASLN | ASLAN Pharmaceuticals Limited | 9.29M | 3.08% | 1,494,565 | 12.00M |
| 588 | CHRO | Chromocell Therapeutics Corp | 9.17M | 11.43% | 16,344 | - |
| 589 | BRTX | BioRestorative Therapies, Inc. | 9.07M | -1.90% | 89,240 | 145.80K |
| 590 | NTBL | Notable Labs, Ltd. | 8.84M | -1.01% | 36,927 | 310.00K |
| 591 | LGVN | Longeveron Inc. | 8.73M | -2.67% | 271,291 | 709.00K |
| 592 | MTEM | Molecular Templates, Inc. | 8.33M | 3.33% | 22,577 | 57.31M |
| 593 | VIRI | Virios Therapeutics, Inc. | 8.30M | 1.25% | 61,255 | - |
| 594 | CYCN | Cyclerion Therapeutics, Inc. | 8.27M | 2.69% | 100 | - |
| 595 | CLDI | Calidi Biotherapeutics, Inc. | 8.18M | 7.05% | 2,041,799 | - |
| 596 | HEPA | Hepion Pharmaceuticals, Inc. | 8.15M | 5.67% | 70,728 | - |
| 597 | AKTX | Akari Therapeutics, Plc | 8.01M | 2.54% | 4,786 | - |
| 598 | NCNA | NuCana plc | 7.93M | -0.25% | 37,241 | - |
| 599 | TFFP | TFF Pharmaceuticals, Inc. | 7.48M | 13.79% | 62,685 | 733.87K |
| 600 | PYPD | PolyPid Ltd. | 7.42M | -0.13% | 895 | - |
| 601 | KTTA | Pasithea Therapeutics Corp. | 7.39M | 4.26% | 731 | - |
| 602 | PULM | Pulmatrix, Inc. | 7.38M | 0.50% | 790 | 7.30M |
| 603 | KA | Kineta, Inc. | 7.34M | 5.50% | 305,572 | 5.44M |
| 604 | KTRA | Kintara Therapeutics, Inc. | 7.34M | 16.10% | 7,525,248 | - |
| 605 | LIXT | Lixte Biotechnology Holdings, Inc. | 7.24M | -2.72% | 40,384 | - |
| 606 | EFTR | eFFECTOR Therapeutics, Inc. | 7.15M | 8.99% | 149,428 | - |
| 607 | VCNX | Vaccinex, Inc. | 7.07M | 3.40% | 7,383 | 570.00K |
| 608 | PSTV | Plus Therapeutics, Inc. | 6.97M | -0.61% | 17,117 | 4.91M |
| 609 | PTIX | Protagenic Therapeutics, Inc. | 6.96M | 30.83% | 71,296 | - |
| 610 | ADIL | Adial Pharmaceuticals, Inc. | 6.89M | -10.53% | 439,727 | - |
| 611 | TENX | Tenax Therapeutics, Inc. | 6.85M | -1.41% | 11,565 | - |
| 612 | CVKD | Cadrenal Therapeutics, Inc. | 6.83M | 4.71% | 108,416 | - |
| 613 | AZTR | Azitra, Inc. | 6.67M | 18.00% | 1,653,855 | 686.00K |
| 614 | ENVB | Enveric Biosciences, Inc. | 6.55M | 4.35% | 70,677 | - |
| 615 | CELZ | Creative Medical Technology Holdings, Inc. | 6.54M | - | 9,592 | 9.00K |
| 616 | TOVX | Theriva Biologics, Inc. | 6.46M | -8.30% | 1,188,209 | - |
| 617 | TTNP | Titan Pharmaceuticals, Inc. | 6.41M | 0.29% | 1,179 | 184.00K |
| 618 | FWBI | First Wave BioPharma, Inc. | 6.32M | 3.31% | 150,917 | - |
| 619 | XBIO | Xenetic Biosciences, Inc. | 5.93M | 1.85% | 2,719 | 2.54M |
| 620 | ATXI | Avenue Therapeutics, Inc. | 5.93M | 3.00% | 281,065 | - |
| 621 | TRVN | Trevena, Inc. | 5.89M | 4.81% | 141,901 | 3.13M |
| 622 | SCPX | Scorpius Holdings, Inc. | 5.77M | 0.95% | 144,229 | 2.23M |
| 623 | MYMD | MyMD Pharmaceuticals, Inc. | 5.52M | -0.78% | 22,725 | - |
| 624 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.46M | 5.33% | 18,191 | 129.18K |
| 625 | PXMD | PaxMedica, Inc. | 5.35M | -4.83% | 728,665 | - |
| 626 | HOTH | Hoth Therapeutics, Inc. | 5.24M | 2.59% | 28,935 | - |
| 627 | NLSP | NLS Pharmaceutics AG | 5.15M | 0.93% | 324,927 | - |
| 628 | SILO | Silo Pharma, Inc. | 5.06M | -9.18% | 5,249,770 | 72.10K |
| 629 | GTBP | GT Biopharma, Inc. | 5.04M | -3.44% | 10,572 | - |
| 630 | ALZN | Alzamend Neuro, Inc. | 4.98M | 5.47% | 19,247 | - |
| 631 | SNPX | Synaptogenix, Inc. | 4.96M | 4.34% | 40,141 | - |
| 632 | OGEN | Oragenics, Inc. | 4.88M | 2.83% | 18,473 | 37.65K |
| 633 | DRUG | Bright Minds Biosciences Inc. | 4.84M | - | 3,423 | - |
| 634 | PRTG | Portage Biotech Inc. | 4.80M | -19.46% | 165,835 | - |
| 635 | NEXI | NexImmune, Inc. | 4.70M | -5.90% | 6,765 | - |
| 636 | XCUR | Exicure, Inc. | 4.67M | 1.85% | 6,200 | 23.79M |
| 637 | PCSA | Processa Pharmaceuticals, Inc. | 4.57M | 4.58% | 24,568 | - |
| 638 | FNCH | Finch Therapeutics Group, Inc. | 4.48M | 22.86% | 654,016 | 107.00K |
| 639 | LIPO | Lipella Pharmaceuticals Inc. | 4.48M | 0.86% | 9,899 | 449.62K |
| 640 | SEEL | Seelos Therapeutics, Inc. | 4.47M | 0.43% | 381,572 | 2.20M |
| 641 | ADTX | Aditxt, Inc. | 4.45M | 2.25% | 25,975 | 645.18K |
| 642 | THAR | Tharimmune, Inc. | 4.45M | 2.32% | 437,445 | - |
| 643 | GNPX | Genprex, Inc. | 4.41M | 6.94% | 30,273 | - |
| 644 | ZVSA | ZyVersa Therapeutics, Inc. | 4.27M | -2.11% | 149,854 | - |
| 645 | ARTL | Artelo Biosciences, Inc. | 4.23M | 0.77% | 15,124 | - |
| 646 | SNGX | Soligenix, Inc. | 4.21M | -1.43% | 406,651 | 839.36K |
| 647 | BPTS | Biophytis S.A. | 4.14M | 8.27% | 9,430 | - |
| 648 | CMND | Clearmind Medicine Inc. | 3.84M | 1.68% | 32,236 | - |
| 649 | MBIO | Mustang Bio, Inc. | 3.74M | 5.79% | 122,879 | - |
| 650 | VRPX | Virpax Pharmaceuticals, Inc. | 3.70M | -4.82% | 11,451 | - |
| 651 | GOVX | GeoVax Labs, Inc. | 3.55M | -3.73% | 31,877 | - |
| 652 | CYTO | Altamira Therapeutics Ltd. | 3.54M | 12.86% | 110,769 | - |
| 653 | CING | Cingulate Inc. | 3.49M | -0.82% | 37,340 | - |
| 654 | REVB | Revelation Biosciences, Inc. | 3.38M | 0.98% | 27,844 | - |
| 655 | WINT | Windtree Therapeutics, Inc. | 3.24M | 1.28% | 81,464 | - |
| 656 | PHIO | Phio Pharmaceuticals Corp. | 3.21M | -15.65% | 642,564 | - |
| 657 | RNAZ | TransCode Therapeutics, Inc. | 3.02M | 0.22% | 98,964 | - |
| 658 | SPRC | SciSparc Ltd. | 3.01M | 0.82% | 111,702 | 2.88M |
| 659 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.90M | -0.56% | 101,574 | 253.57K |
| 660 | NBY | NovaBay Pharmaceuticals, Inc. | 2.78M | 6.21% | 1,564,470 | 14.73M |
| 661 | ONCO | Onconetix, Inc. | 2.66M | -1.49% | 635,474 | 58.47K |
| 662 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.36M | 2.29% | 28,374 | 420.00K |
| 663 | DRMA | Dermata Therapeutics, Inc. | 2.26M | 0.32% | 19,497 | - |
| 664 | CNSP | CNS Pharmaceuticals, Inc. | 2.23M | 7.14% | 120,693 | - |
| 665 | SLRX | Salarius Pharmaceuticals, Inc. | 2.16M | -1.76% | 15,480 | - |
| 666 | SCNI | Scinai Immunotherapeutics Ltd. | 2.10M | 2.96% | 4,944 | - |
| 667 | BPTH | Bio-Path Holdings, Inc. | 2.02M | -8.05% | 316,574 | - |
| 668 | QLGN | Qualigen Therapeutics, Inc. | 1.99M | 7.80% | 12,885 | - |
| 669 | ENSC | Ensysce Biosciences, Inc. | 1.76M | 0.96% | 43,795 | - |
| 670 | INM | InMed Pharmaceuticals Inc. | 1.65M | 0.81% | 89,207 | 5.49M |
| 671 | ATNF | 180 Life Sciences Corp. | 1.62M | 5.56% | 48,003 | - |
| 672 | NBSE | NeuBase Therapeutics, Inc. | 1.58M | 2.43% | 58,233 | - |
| 673 | TCBP | TC Biopharm (Holdings) Plc | 1.52M | 0.32% | 112,989 | - |
| 674 | VRAX | Virax Biolabs Group Limited | 1.49M | -3.24% | 39,693 | 79.30K |
| 675 | GRI | GRI Bio, Inc. | 1.43M | -4.28% | 143,175 | - |
| 676 | GLMD | Galmed Pharmaceuticals Ltd. | 1.38M | -0.63% | 66,290 | - |
| 677 | ALLR | Allarity Therapeutics, Inc. | 669.07K | - | 797,739 | - |
| 678 | QNRX | Quoin Pharmaceuticals, Ltd. | 651.57K | - | 82,684 | - |
| 679 | APVO | Aptevo Therapeutics Inc. | 495.78K | 3.69% | 345,239 | - |
| 680 | BDRX | Biodexa Pharmaceuticals Plc | 191.13K | 3.60% | 77,418 | 482.28K |